| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a3729aaa0bcf605fedf5fb0c4ba0860
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_929cc02245a232f4686203efa32448c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d14081871dbb6767d24058a71f757f94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23ae613813c6d060ed8c6c4c053f39c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b64af3ed2e972b234914dd1188566069 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0698
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-36 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2006-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f63cc77c978700e9a695e07344e9e864
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6019afcbf2541c3a589aea3552e6e822
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a283cd399cc0c855a0ccd3096a2aaf16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d209ee72f4bdd9d94b25bfd7cfefc2e |
| publicationDate |
2007-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007061168-A1 |
| titleOfInvention |
Pharmaceutical compositions for cell therapy of pigmentation disorders |
| abstract |
The present invention relates to a pharmaceutical composition for cell therapy of pigmentation disorders, which comprises as an active ingredient (a) melanocytes and keratinocytes, or (b) melanocytes and fibroblasts. The cell therapy composition of this invention allows for the first time to treat pigmentation disorders through cell therapy regimen. The present composition comprises as active ingredients a mixed cell preparation of melanocytes and keratinocytes or a mixed cell preparation of melanocytes and fibroblasts such that it induces very effectively pigmentation to treat diseases associated with hypopig mentation such as vitiligo. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016053785-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103983762-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2103687-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3336175-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10612004-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101538555-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3889247-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020111271-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016144472-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018112188-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016151134-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009219491-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2928654-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11643639-B2 |
| priorityDate |
2005-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |